Case number 2:22-cv-00718
PACIRA PHARMACEUTICALS, INC. et al v. EVENUS PHARMACEUTICALS LABORATORIES INC. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 27, 2024 | 31 | Notice of Appeal* (1) |
| Dec 15, 2022 | 26 | DECLARATION of Kevin DeJong, Esq. re 25 Brief, Declaration in Support of Defendants' Responsive Claim Construction Brief by All Defendants. (Attachments: # 1 Exhibit Exhibit 26, # 2 Exhibit Exhibit 27)(MURTHA, WILLIAM) (Entered: 12/15/2022) (0) |
| Dec 15, 2022 | 25 | BRIEF Responsive Claim Construction (MURTHA, WILLIAM)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 12/15/2022) (0) |
| May 9, 2022 | 24 | Order (2) Docket Text: ORDER CONSOLIDATING CASES that Civil Action No. 2:21-19829-MCA-JRA and Civil Action No. 2:22-718-MCA-JRA are consolidated for all purposes, including pretrial discovery, hearings, case management, and trial; etc. Signed by Magistrate Judge Jose R. Almonte on 5/9/2022. (sm) |
| May 6, 2022 | 23 | Order on Motion to Seal (3) Docket Text: ORDER granting [18] Motion to Seal; that the Clerk of the Court shall permit the Confidential Materials to be sealed permanently, and the Clerk shall take such other steps as may be reasonably required to maintain the confidentiality of the Confidential Materials.. Signed by Magistrate Judge Jose R. Almonte on 5/5/2022. (ld, ) |
| May 6, 2022 | 22 | Answer to Counterclaim (12) Docket Text: ANSWER to Counterclaim by PACIRA BIOSCIENCES, INC., PACIRA PHARMACEUTICALS, INC..(BETZ, CYNTHIA) |
| Apr 25, 2022 | N/A | Set/Reset Motion and R&R Deadlines/Hearings (0) Docket Text: Set Deadlines as to [18] MOTION to Seal . Motion set for 5/16/2022 before Judge Madeline Cox Arleo. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (ams, ) |
| Apr 19, 2022 | 21 | Corporate Disclosure Statement (aty) (3) Docket Text: Corporate Disclosure Statement by FRESENIUS KABI USA, LLC identifying Fresenius Kabi Pharmaceuticals Holding, LLC as Corporate Parent.. (ABRAHAM, ERIC) |
| Apr 19, 2022 | 20 | Corporate Disclosure Statement (aty) (3) Docket Text: Corporate Disclosure Statement by JIANGSU HENGRUI PHARMACEUTICALS CO. LTD.. (ABRAHAM, ERIC) |
| Apr 19, 2022 | 19 | Corporate Disclosure Statement (aty) (3) Docket Text: Corporate Disclosure Statement by EVENUS PHARMACEUTICALS LABORATORIES INC. identifying JJIANGSU HENGRUI PHARMACEUTICAL CO. LTD. as Corporate Parent.. (ABRAHAM, ERIC) |
| Apr 18, 2022 | 18 | Text of Proposed Order (4) |
| Apr 18, 2022 | 18 | Statement Local Rule 7.1 Statement (2) |
| Apr 18, 2022 | 18 | Exhibit Redacted First Complaint (53) |
| Apr 18, 2022 | 18 | Exhibit Redacted Amended Answer (62) |
| Apr 18, 2022 | 18 | Declaration Ryan Daniel (3) |
| Apr 18, 2022 | 18 | Index (2) |
| Apr 18, 2022 | 18 | Declaration Eric I. Abraham, Esq. (5) |
| Apr 18, 2022 | 18 | Main Document (2) Docket Text: MOTION to Seal by EVENUS PHARMACEUTICALS LABORATORIES INC., FRESENIUS KABI USA, LLC, JIANGSU HENGRUI PHARMACEUTICALS CO. LTD.. (Attachments: # (1) Declaration Eric I. Abraham, Esq., # (2) Index, # (3) Declaration Ryan Daniel, # (4) Exhibit Redacted Amended Answer, # (5) Exhibit Redacted First Complaint, # (6) Statement Local Rule 7.1 Statement, # (7) Text of Proposed Order)(ABRAHAM, ERIC) |
| Apr 12, 2022 | N/A | QC - Generic Message (0) Docket Text:CLERK'S QUALITY CONTROL MESSAGE - Please be advised that Attorney Alison Siedor referenced in D.E. [16], is not admitted Pro Hac Vice in this matter. The Clerk's Office will take no action. (ams, ) |
| Apr 11, 2022 | 16 | Notice of Change of Address (3) Docket Text: NOTICE of Change of Address by ERIC I. ABRAHAM (ABRAHAM, ERIC) |
| Apr 7, 2022 | N/A | Update Answer Due Deadline (0) Docket Text: Clerk`s Text Order - The document [15] Application for Clerk's Order to Ext Answer/Proposed Order submitted by JIANGSU HENGRUI PHARMACEUTICALS CO. LTD., EVENUS PHARMACEUTICALS LABORATORIES INC. has been GRANTED. The answer due date has been set for 4/18/2022. (ams, ) |
| Apr 6, 2022 | 15 | Application for Clerk's Order to Ext Answer/Proposed Order (3) Docket Text: Application and Proposed Order for Clerk's Order to extend time to answer as to Defendants.. (ABRAHAM, ERIC) |
| Apr 1, 2022 | 14 | Acknowledgment of Service (2) Docket Text: ACKNOWLEDGMENT OF SERVICE Executed by PACIRA PHARMACEUTICALS, INC., PACIRA BIOSCIENCES, INC.. FRESENIUS KABI USA, LLC served on 3/28/2022, answer due 4/18/2022. (BETZ, CYNTHIA) |
| Mar 25, 2022 | 13 | Redacted Document (30) Docket Text: REDACTION to [10] Amended Complaint by PACIRA BIOSCIENCES, INC., PACIRA PHARMACEUTICALS, INC.. (BETZ, CYNTHIA) |
| Mar 25, 2022 | 12 | Certificate of Service (2) Docket Text: CERTIFICATE OF SERVICE by PACIRA BIOSCIENCES, INC., PACIRA PHARMACEUTICALS, INC. re [11] Exhibit (to Document), [10] Amended Complaint (FLAHERTY, JOHN) |
| Mar 25, 2022 | 11 | Exhibit (23) |
| Mar 25, 2022 | 11 | Exhibit (36) |
| Mar 25, 2022 | 11 | Main Document (22) Docket Text: Exhibit to [10] Amended Complaint by PACIRA BIOSCIENCES, INC., PACIRA PHARMACEUTICALS, INC.. (Attachments: # (1) Exhibit, # (2) Exhibit)(FLAHERTY, JOHN) |
| Mar 24, 2022 | 9 | Letter (1) Docket Text: Letter from Plaintiffs to Hon. Jose R. Almonte, U.S.M.J.. (BETZ, CYNTHIA) |
| Mar 15, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Magistrate Judge Jose R. Almonte. Magistrate Judge Cathy L. Waldor no longer assigned to the case. (ak, ) |
| Mar 9, 2022 | 8 | Application for Clerk's Order to Ext Answer/Proposed Order (3) Docket Text: Application and Proposed Order for Clerk's Order to extend time to answer as to Defendants. Attorney ERIC I. ABRAHAM,WILLIAM MURTHA for EVENUS PHARMACEUTICALS LABORATORIES INC.,ERIC I. ABRAHAM,WILLIAM MURTHA for JIANGSU HENGRUI PHARMACEUTICALS CO. LTD. added. (MURTHA, WILLIAM) |
| Mar 9, 2022 | 7 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by WILLIAM MURTHA on behalf of EVENUS PHARMACEUTICALS LABORATORIES INC., JIANGSU HENGRUI PHARMACEUTICALS CO. LTD. (MURTHA, WILLIAM) |
| Mar 9, 2022 | 6 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by ERIC I. ABRAHAM on behalf of EVENUS PHARMACEUTICALS LABORATORIES INC., JIANGSU HENGRUI PHARMACEUTICALS CO. LTD. (ABRAHAM, ERIC) |
| Mar 9, 2022 | N/A | Update Answer Due Deadline (0) Docket Text: Clerk`s Text Order - The document [8] Application for Clerk's Order to Ext Answer/Proposed Order, submitted by JIANGSU HENGRUI PHARMACEUTICALS CO. LTD., EVENUS PHARMACEUTICALS LABORATORIES INC. has been GRANTED. The answer due date has been set for 3/24/2022. (ams, ) |
| Feb 14, 2022 | 5 | Complaint and Exhibits (134) |
| Feb 14, 2022 | 5 | Main Document (1) Docket Text: AO120 Patent/Trademark Form filed. (ams, ) (Additional attachment(s) added on 2/14/2022: # (1) Complaint and Exhibits) (ams, ). |
| Feb 14, 2022 | N/A | Add and Terminate Judges (0) Docket Text: Judge Madeline Cox Arleo and Magistrate Judge Cathy L. Waldor added. (ps) |
| Feb 10, 2022 | 4 | Summons Issued (2) Docket Text: SUMMONS ISSUED as to EVENUS PHARMACEUTICALS LABORATORIES INC., JIANGSU HENGRUI PHARMACEUTICALS CO. LTD. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (mxw) |
| Feb 10, 2022 | 3 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by CYNTHIA STENCEL BETZ on behalf of PACIRA BIOSCIENCES, INC., PACIRA PHARMACEUTICALS, INC. (BETZ, CYNTHIA) |
| Feb 10, 2022 | 2 | Corporate Disclosure Statement (aty) (2) Docket Text: Corporate Disclosure Statement by PACIRA BIOSCIENCES, INC., PACIRA PHARMACEUTICALS, INC. identifying Pacira Biosciences, Inc. as Corporate Parent.. (FLAHERTY, JOHN) |
| Feb 10, 2022 | 1 | Statement - Corporate Disclosure Statement (2) |
| Feb 10, 2022 | 1 | Civil Cover Sheet (2) |
| Feb 10, 2022 | 1 | Exhibit C - U.S. Patent No. 11,179,336 (23) |
| Feb 10, 2022 | 1 | Complaint* (1) |
| Feb 10, 2022 | 1 | Exhibit B - EXPAREL PRESCRIBING INFORMATION (Current) (36) |
| Feb 10, 2022 | 1 | Exhibit A - U.S. Patent No. 11,033,495 (22) |
| Feb 10, 2022 | 1 | Main Document (49) Docket Text: COMPLAINT against EVENUS PHARMACEUTICALS LABORATORIES INC., JIANGSU HENGRUI PHARMACEUTICALS CO. LTD. ( Filing and Admin fee $ 402 receipt number ANJDC-13178954) , Related Case Selected, filed by PACIRA PHARMACEUTICALS, INC., PACIRA BIOSCIENCES, INC.. (Attachments: # (1) Exhibit A - U.S. Patent No. 11,033,495, # (2) Exhibit B - EXPAREL PRESCRIBING INFORMATION (Current), # (3) Exhibit C - U.S. Patent No. 11,179,336, # (4) Civil Cover Sheet, # (5) Statement - Corporate Disclosure Statement)(FLAHERTY, JOHN) |
